Article

Sprung, VS, Kemp, GJ, Wilding, JP, Adams, V, Murphy, K, Burgess, M, Emegbo, S, Thomas, M, Needham, AJ, Weimken, A, Schwab, RJ, Manuel, A, Craig, SE and Cuthbertson, DJ (2020) Randomised, cOntrolled Multicentre trial of 26 weeks subcutaneous liraglutide (a glucagon-like peptide-1 receptor Agonist), with or without contiNuous positive airway pressure (CPAP), in patients with type 2 diabetes mellitus (T2DM) and obstructive sleep apnoEa (OSA) (ROMANCE): study protocol assessing the effects of weight loss on the apnea-hypnoea index (AHI). BMJ Open, 10 (7). ISSN 2044-6055

Dobson, R, Burgess, MI, Sprung, VS, Irwin, A, Hamer, M, Jones, J, Daousi, C, Adams, V, Kemp, GJ, Shojaee-Moradie, F, Umpleby, M and Cuthbertson, DJ (2015) Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity. International Journal of Obesity, 40 (1). pp. 153-161. ISSN 0307-0565